• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

INES:用于构建和外推分区生存模型的交互式工具。

INES: Interactive tool for construction and extrapolation of partitioned survival models.

作者信息

Gimeno-Ballester Vicente, Perez-Troncoso Daniel, Olry-Labry Antonio, Epstein David

机构信息

Servicio de Farmacia, Hospital Universitario Miguel Servet, Zaragoza, Spain.

Agència De Qualitat I Avaluació Sanitàries De Catalunya, Barcelona, Spain.

出版信息

Cost Eff Resour Alloc. 2023 Jul 31;21(1):48. doi: 10.1186/s12962-023-00456-6.

DOI:10.1186/s12962-023-00456-6
PMID:37525183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10391963/
Abstract

BACKGROUND

INES (INteractive model for Extrapolation of Survival and cost) provides an open-access tool powered by R that implements three-state partitioned survival models (PSM). This article describes the properties of the tool, and the situations where INES may or may not be suitable.

METHODS

INES is designed to be used by investigators or healthcare professionals who have a good grasp of the principles of economic evaluation and understand the strengths and weaknesses of partitioned survival models, but are not sufficiently familiar with a statistical package such as Excel or R to be able to construct and test a de-novo PSM themselves. INES is delivered to the user via a batch file. Once downloaded to the user's hard drive, it interacts with the user via a portable version of R with web interactivity built in Shiny. INES requires absolutely no knowledge of R and the user does not need to have R or any of its dependences installed. Hence the user will deal with a standalone Shiny app. Inputs (digitalized survival curves, unit costs, posology, hazard ratios, discount rate) can be uploaded from a template spreadsheet.

RESULTS

The INES application provides a seamlessly integrated package for estimating a set of parametric hazard functions for progression free and overall survival, selecting an appropriate function from this menu, and applying this as an input to a PSM to calculate mean costs and quality-adjusted life years. Examples are given that may serve as a tutorial.

CONCLUSION

INES offers a rapid, flexible, robust and transparent tool for parametric survival analysis and calculating a PSM that can be used in many different contexts.

摘要

背景

INES(生存与成本外推交互式模型)提供了一个由R驱动的开放获取工具,该工具实现了三状态分区生存模型(PSM)。本文描述了该工具的特性,以及INES可能适用或不适用的情况。

方法

INES旨在供那些很好地掌握经济评估原则并理解分区生存模型优缺点,但对诸如Excel或R等统计软件包不够熟悉,无法自行构建和测试全新PSM的研究人员或医疗保健专业人员使用。INES通过批处理文件交付给用户。一旦下载到用户的硬盘驱动器上,它会通过内置Shiny网络交互功能的R便携版本与用户进行交互。INES绝对不需要R的知识,用户也无需安装R或其任何依赖项。因此,用户将处理一个独立的Shiny应用程序。输入(数字化生存曲线、单位成本、用药剂量、风险比、贴现率)可以从模板电子表格中上传。

结果

INES应用程序提供了一个无缝集成的软件包,用于估计无进展生存和总生存的一组参数风险函数,从该菜单中选择合适的函数,并将其作为输入应用于PSM以计算平均成本和质量调整生命年。给出了一些示例,可作为教程。

结论

INES为参数生存分析和计算PSM提供了一个快速、灵活、稳健且透明的工具,可用于许多不同的情境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a40/10391963/2b1dc77cfaa8/12962_2023_456_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a40/10391963/c94c143a5967/12962_2023_456_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a40/10391963/2b1dc77cfaa8/12962_2023_456_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a40/10391963/c94c143a5967/12962_2023_456_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a40/10391963/2b1dc77cfaa8/12962_2023_456_Fig2_HTML.jpg

相似文献

1
INES: Interactive tool for construction and extrapolation of partitioned survival models.INES:用于构建和外推分区生存模型的交互式工具。
Cost Eff Resour Alloc. 2023 Jul 31;21(1):48. doi: 10.1186/s12962-023-00456-6.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Making health economic models Shiny: A tutorial.让健康经济模型变得出色:教程
Wellcome Open Res. 2020 Jul 31;5:69. doi: 10.12688/wellcomeopenres.15807.2. eCollection 2020.
4
5
Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes.评估用于成本效益分析的分区生存和马尔可夫决策分析模型方法:估计和比较生存结果。
Pharmacoeconomics. 2020 Jan;38(1):97-108. doi: 10.1007/s40273-019-00845-x.
6
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.KTE-X19 治疗美国成人复发/难治性 B 细胞急性淋巴细胞白血病的成本效果分析。
Adv Ther. 2022 Aug;39(8):3678-3695. doi: 10.1007/s12325-022-02201-6. Epub 2022 Jun 21.
7
Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA.开发一个交互式网络工具,用于进行和查询诊断测试准确性研究的荟萃分析:MetaDTA。
BMC Med Res Methodol. 2019 Apr 18;19(1):81. doi: 10.1186/s12874-019-0724-x.
8
NormalizeMets: assessing, selecting and implementing statistical methods for normalizing metabolomics data.NormalizeMets:评估、选择和实施代谢组学数据标准化的统计方法。
Metabolomics. 2018 Mar 20;14(5):54. doi: 10.1007/s11306-018-1347-7.
9
A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation; three case studies of treatments for glioblastoma multiforme.发表的时不变马尔可夫模型与分割生存模型在成本效果估计中的比较;多形性胶质母细胞瘤三种治疗方法的案例研究。
Eur J Health Econ. 2021 Feb;22(1):89-100. doi: 10.1007/s10198-020-01239-z. Epub 2020 Nov 1.
10
Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma.单药与联合免疫肿瘤疗法的经济学评估:一种新型建模方法在转移性黑色素瘤中的应用
Clinicoecon Outcomes Res. 2020 May 6;12:241-252. doi: 10.2147/CEOR.S238725. eCollection 2020.

本文引用的文献

1
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.曲妥珠单抗-德鲁替康与曲妥珠单抗-美坦新用于乳腺癌。
N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022.
2
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.达雷妥尤单抗治疗免疫球蛋白轻链淀粉样变性。
N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631.
3
IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves.KM-IPD: 从已发表的 Kaplan-Meier 生存曲线中重建个体患者数据。
BMC Med Res Methodol. 2021 Jun 1;21(1):111. doi: 10.1186/s12874-021-01308-8.
4
Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now?肿瘤学中用于医疗保健决策的分区生存和状态转移模型:我们现在在哪里?
Value Health. 2020 Dec;23(12):1613-1621. doi: 10.1016/j.jval.2020.08.2094. Epub 2020 Oct 17.
5
GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.GRADE 指南 30:建模证据确定性评估的 GRADE 方法——在卫生决策背景下的概述。
J Clin Epidemiol. 2021 Jan;129:138-150. doi: 10.1016/j.jclinepi.2020.09.018. Epub 2020 Sep 24.
6
Pricing methods in outcome-based contracting: δ6: adherence-based pricing.基于结果的合同定价方法:δ6:基于依从性的定价。
J Med Econ. 2020 Nov;23(11):1256-1265. doi: 10.1080/13696998.2020.1815030. Epub 2020 Sep 10.
7
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?中位生存时间与平均生存时间:哪项指标对患者、医生和决策者最适用?
Oncologist. 2019 Nov;24(11):1469-1478. doi: 10.1634/theoncologist.2019-0175. Epub 2019 Jul 18.
8
Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment.肿瘤学建模,乐趣与收益并存!健康技术评估中忙碌分析师的关键步骤。
Pharmacoeconomics. 2018 Jan;36(1):7-15. doi: 10.1007/s40273-017-0583-4.
9
Bayesian Solutions for Handling Uncertainty in Survival Extrapolation.用于处理生存外推中不确定性的贝叶斯解决方案。
Med Decis Making. 2017 May;37(4):367-376. doi: 10.1177/0272989X16650669. Epub 2016 Jun 8.
10
Survival analysis for economic evaluations alongside clinical trials--extrapolation with patient-level data: inconsistencies, limitations, and a practical guide.生存分析在临床试验中的经济评估——利用患者水平数据进行外推:不一致性、局限性和实用指南。
Med Decis Making. 2013 Aug;33(6):743-54. doi: 10.1177/0272989X12472398. Epub 2013 Jan 22.